Low-dose ICS remain essential for every asthma patient, and GINA/CFA guidance favors phenotype-tailored step-up strategies ...

Urban adolescents with poorly controlled asthma participating in an e-health intervention had improved asthma self-efficacy ...

On May 5, 2025, the Global Initiative For Asthma (GINA) published the 2026 update to their Global Strategy for Asthma ...

Both patients with asthma who switched from mepolizumab/benralizumab to depemokimab and patients who continued ...

Biologic therapies have transformed the management of paediatric severe asthma, yet response remains highly variable and unpredictable. A critical but ...

Respiratory consultant emphasises the importance of personalised action plans to manage symptoms, while community care brings ...

Japan: A study published in Thorax has found that patients with asthma and neuropathic or chronic pain who used ...

Modern asthma research suggests exercise itself is rarely the real danger. Poor asthma control, inactivity, pollution, and ...

Are you ignoring the signs of uncontrolled asthma? Frequent wheezing and over-reliance on reliever inhalers could lead to serious health risks. Discover how to manage your asthma effectively ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Brits who puff on blue inhalers to open their airways and ease their breathing have been urged to reconsider their 'asthma action plans' as soon as.

Historically, short-acting β2-agonists (SABAs) have been the preferred reliever therapy for asthma. However, their excessive use is associated with poor treatment outcomes, prompting the recent Global ...